Viracta Therapeutics Overview

Viracta Therapeutics Other Income Expense Net

Other Income/Expense Net for VIRX.

Quarterly Other Income/Expense

-$368000.00

↓ 194.4% YoY

As of Sep 30, 2024

Annual Other Income/Expense (TTM)

$3.92M

↑ 232.85% YoY

Trailing 12 months ending Sep 30, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin